Yıl: 2019 Cilt: 4 Sayı: 2 Sayfa Aralığı: 84 - 89 Metin Dili: İngilizce DOI: 10.5152/cjms.2019.818 İndeks Tarihi: 10-09-2020

Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis

Öz:
BACKGROUND/AIMSSystemic sclerosis (SSc) is a chronic inflammatory multisystem disorder characterized by microvascular damage and extensive fibrosis. Cardiopulmonary involvement is strongly associated with the severity of the disease itself and the mortality and morbidity of SSc. The aim of this study was to evaluate cardiopulmonary functions and aerobic capacity of SSc patients through cardiopulmonary exercise testing and compare them to healthy individuals.MATERIAL and METHODSA total of 27 patients (25 females, 2 males; mean age 43.96±13.01 years; mean body mass index 26.34±5.33 kg/m2) who were diagnosed with SSc according to the American Rheumatism Association criteria and a control group of 23 healthy age-matched individuals (18 females, 5 males; mean age 42.04±12.28 years; mean body mass index 26.89±3.99 kg/m2) were included in the study. All subjects underwent a treadmill cardiopulmonary exercise test. A computerized gas analysis system collected and analyzed expired gases during the exercise.RESULTSThe mean peak oxygen consumptions were significantly decreased in the patient group (14.09±6.24 mL/kg/minute) as compared to the control group (19.65±5.97 mL/kg/minute) (p=0.002). In addition, the patient group had significantly lower peak minute ventilation (p=0.011), O2 pulse (p=0.003), and exercise time (p=0.027), while having higher VD/VT rest and VD/VT peak in comparison with the control group.CONCLUSIONThe results of this study showed that patients with SSc had a lower aerobic capacity as compared to healthy individuals. The cardiopulmonary exercise test is a useful tool to detect exercise intolerance and provide additional information on the mechanism of exercise limitation in SSc.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43: 2437-44. [CrossRef]
  • 2. Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology (Oxford) 2009; 48: iii45-8. [CrossRef]
  • 3. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2012; 51: 1017-26. [CrossRef]
  • 4. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med 1988; 24: 1379-84. [CrossRef]
  • 5. Adult Cardiopulmonary Exercise Testing. Available from: URL: https://www.health.qld.gov.au/__data/assets/pdf_file/0023/147515/qh-gdl-958.pdf.
  • 6. Blom-Bülow B, Jonson B, Bauer K. Factors limiting exercise performance in progressive systemic sclerosis. Semin Arthritis Rheum 1983; 13: 174-81. [CrossRef]
  • 7. Boutou AK, Pitsiou GG, Siakka P, Dimitroulas T, Paspala A, Sourla E, et al. Phenotyping Exercise Limitation in Systemic Sclerosis: The Use of Cardiopulmonary Exercise Testing. Respiration 2016; 91: 115-23. [CrossRef]
  • 8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90. [CrossRef]
  • 9. Bruce RA, Cooper MN, Gey GO, Fisher LD, Peterson DR. Variations in responses to maximal exercise in health and in cardiovascular disease. Angiology 1973; 24: 691-702. [CrossRef]
  • 10. American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 2003; 167: 211-77. [CrossRef]
  • 11. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, et al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum 2005; 52: 592-600. [CrossRef]
  • 12. Arakkal G, Chintagunta SR, Chandika V, Damarla SV, Manchala S, Kumar BU. Cardio-pulmonary involvement in systemic sclerosis: A study at a tertiary care center. Indian J Dermatol Venereol Leprol 2017; 83: 677-82. [CrossRef]
  • 13. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-7. [CrossRef]
  • 14. Alkotob ML, Soltani P, Sheatt MA, Katsetos MC, Rothfield N, Hager WD, et al. Reduced exercise capacity and stress induces pulmonary hypertension in patients with scleroderma. Chest 2006; 130: 176-81. [CrossRef]
  • 15. Datta D, Normandin E, ZuWallack R. Cardiopulmonary exercise testing in the assessment of exertional dyspnea. Ann Thorac Med 2015; 10: 77-86. [CrossRef]
  • 16. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-77. [CrossRef]
  • 17. Morelli S, Ferrante L, Sgreccia A, Eleuteri ML, Perrone C, De Marzio P, et al. Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol 2000; 29: 236-42. [CrossRef]
  • 18. Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Collop NA, et al. Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med 1993; 95: 413-8. [CrossRef]
  • 19. de Oliveira NC, dos Santos Sabbag LM, Ueno LM, de Souza RB, Borges CL, de Sá Pinto AL, et al. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement. Scand J Rheumatol 2007; 36: 458-61. [CrossRef]
  • 20. Płazak W, Heród P, Drapisz S, Tomkiewicz‐Pająk L, Wrzosek J, Musiał J, et al. Influence of disease‐related heart pathology on peak oxygen uptake and ventilation/carbon dioxide output ratio in systemic sclerosis and systemic lupus erythematosus patients (RCD code: I‐3C). Journal of Rare Cardiovascular Diseases 2013; 1: 96-102. [CrossRef]
  • 21. Rosato E, Romaniello A, Magrì D, Bonini M, Sardo L, Gigante A, et al. Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables. Clin Exp Rheumatol 2014; 32: 103-8.
  • 22. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, et al. EACPR; AHA. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012; 33: 2917-27. [CrossRef]
  • 23. Schwaiblmair M, Behr J, Fruhmann G. Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996; 110: 1520-5. [CrossRef]
  • 24. Joshi JM, Gothi D. Routine use of pulse oximetry in out-patient department. Indian J Chest Dis Allied Sci 2009; 51: 5-6.
  • 25. Harris-Eze AO, Sridhar G, Clemens RE, Gallagher CG, Marciniuk DD. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med 1994; 150: 1616-22. [CrossRef]
  • 26. Villalba WO, Sampaio-Barros PD, Pereira MC, Cerqueira EM, Leme CA Jr, Marques-Neto JF, et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest 2007; 131: 217-22. [CrossRef]
  • 27. Ciurzyński M, Bienias P, Lichodziejewska B, Szewczyk A, Glińska-Wielochowska M, Jankowski K, et al. Assessment of left and right ventricular diastolic function in patients with systemic sclerosis. Kardiol Pol 2008; 66: 269-76.
  • 28. Weisman IM, Zeballos RJ. An Integrative Approach to the Interpretation of Cardiopulmonary Exercise Testing Clinical Exercise Testing. Prog Respir Res 2002; 32: 300-22. [CrossRef]
  • 29. Ponikowski P, Francis DP, Piepoli MF, Davies LC, Chua TP, Davos CH, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103: 967-72. [CrossRef]
APA kesikburun b, KOSEOGLU B, Doğan A, ŞAHİN A, TURGAY T (2019). Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. , 84 - 89. 10.5152/cjms.2019.818
Chicago kesikburun bilge,KOSEOGLU BELMA F?SUN,Doğan Asuman,ŞAHİN Ali,TURGAY TAHSİN MURAT Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. (2019): 84 - 89. 10.5152/cjms.2019.818
MLA kesikburun bilge,KOSEOGLU BELMA F?SUN,Doğan Asuman,ŞAHİN Ali,TURGAY TAHSİN MURAT Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. , 2019, ss.84 - 89. 10.5152/cjms.2019.818
AMA kesikburun b,KOSEOGLU B,Doğan A,ŞAHİN A,TURGAY T Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. . 2019; 84 - 89. 10.5152/cjms.2019.818
Vancouver kesikburun b,KOSEOGLU B,Doğan A,ŞAHİN A,TURGAY T Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. . 2019; 84 - 89. 10.5152/cjms.2019.818
IEEE kesikburun b,KOSEOGLU B,Doğan A,ŞAHİN A,TURGAY T "Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis." , ss.84 - 89, 2019. 10.5152/cjms.2019.818
ISNAD kesikburun, bilge vd. "Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis". (2019), 84-89. https://doi.org/10.5152/cjms.2019.818
APA kesikburun b, KOSEOGLU B, Doğan A, ŞAHİN A, TURGAY T (2019). Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. Cyprus Journal of Medical Sciences, 4(2), 84 - 89. 10.5152/cjms.2019.818
Chicago kesikburun bilge,KOSEOGLU BELMA F?SUN,Doğan Asuman,ŞAHİN Ali,TURGAY TAHSİN MURAT Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. Cyprus Journal of Medical Sciences 4, no.2 (2019): 84 - 89. 10.5152/cjms.2019.818
MLA kesikburun bilge,KOSEOGLU BELMA F?SUN,Doğan Asuman,ŞAHİN Ali,TURGAY TAHSİN MURAT Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. Cyprus Journal of Medical Sciences, vol.4, no.2, 2019, ss.84 - 89. 10.5152/cjms.2019.818
AMA kesikburun b,KOSEOGLU B,Doğan A,ŞAHİN A,TURGAY T Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. Cyprus Journal of Medical Sciences. 2019; 4(2): 84 - 89. 10.5152/cjms.2019.818
Vancouver kesikburun b,KOSEOGLU B,Doğan A,ŞAHİN A,TURGAY T Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis. Cyprus Journal of Medical Sciences. 2019; 4(2): 84 - 89. 10.5152/cjms.2019.818
IEEE kesikburun b,KOSEOGLU B,Doğan A,ŞAHİN A,TURGAY T "Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis." Cyprus Journal of Medical Sciences, 4, ss.84 - 89, 2019. 10.5152/cjms.2019.818
ISNAD kesikburun, bilge vd. "Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis". Cyprus Journal of Medical Sciences 4/2 (2019), 84-89. https://doi.org/10.5152/cjms.2019.818